Dana-Farber to retract six papers, correct 31, over “image discrepancies” in papers co-authored by top leaders January 26, 2024Vol.50 No.04By Jacquelyn Cobb
Real-world Evidence Flatiron, Caris combine EHR, multi-omics data to support precision oncology January 26, 2024Vol.50 No.04By Matthew Bin Han Ong
Guest Editorial The growing need for cancer patient navigation and how to meet it January 26, 2024Vol.50 No.04By Alyssa Schatz and Crystal S. Denlinger
Guest Editorial Reflecting on Janet Woodcock’s retirement from FDA January 26, 2024Vol.50 No.04By Ellen V. Sigal
FreeIn the Archives Breaking barriers: Edith Mitchell’s extraordinary life January 26, 2024Vol.50 No.04
FreeGuest Editorial Black leaders in oncology urge the White House to finalize the menthol ban January 19, 2024Vol.50 No.03By Selwyn M. Vickers, Adekunle “Kunle” Odunsi, Alex A. Adjei, John D. Carpten, Robert A. Winn, Taofeek K. Owonikoko, Edith P. Mitchell and Otis W. Brawley
FreeGuest Editorial Biden must stand up to pressure from advocates for menthol–even if they are Black January 19, 2024Vol.50 No.03By Otis W. Brawley
Cancer History ProjectFree Former HHS Secretary Louis Sullivan recalls sinking RJR’s “Uptown,” a menthol brand for Black smokers January 19, 2024Vol.50 No.03By Alan Blum and Alexandria Carolan
ACS report: 2024 projected new cancer cases top 2 million January 19, 2024Vol.50 No.03By Jacquelyn Cobb
FreeIn the Archives The boy who cried vape: Philip Morris calls for a smoke-free world January 19, 2024Vol.50 No.03By Alan Blum
